Eric Feinstein

Eric Feinstein is the President and CEO of Clarapath, a Hawthorne, New York medical robotics company automating one of the last manual corners of the pathology lab: cutting and mounting tissue for diagnosis. Under his leadership Clarapath built SectionStar, an FDA-registered robotic microtomy platform, acquired the digital-pathology software firm Crosscope, forged a research collaboration with Mayo Clinic, and closed a $36M Series B in 2024. A former medical-device investor and operator with an MBA from Cornell, Feinstein frames the histology lab as a Lean Six Sigma manufacturing operation and pitches a broader vision he calls Laboratory 2.0.